Oncolix, Inc. Proceeds from Stock Options Exercised
Oncolix, Inc. reported Proceeds from Stock Options Exercised of $1.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2018-11-19
- Oncolix, Inc. proceeds from stock options exercised for the quarter ending 2017-12-31 was $0.00.
- Oncolix, Inc. proceeds from stock options exercised for the quarter ending 2016-12-31 was $0.00.
- Oncolix, Inc. proceeds from stock options exercised for the quarter ending 2016-09-30 was $0.00.
- Oncolix, Inc. proceeds from stock options exercised for fiscal 2017 was $1.00K, a 0.00% change from fiscal 2016.
- Oncolix, Inc. proceeds from stock options exercised for fiscal 2016 was $1.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $1.00K 10-K · filed 2018-03-14 | ||
| 2017-09-30 | $1.00K 10-Q · filed 2018-11-19 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | $1.00K 10-K · filed 2018-03-14 | |
| 2016-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-11-24 | $1.00K 10-Q/A · filed 2017-11-24 | ||
| 2016-06-30 | $1.00K 10-Q · filed 2017-08-18 |